BALTIMORE, March 11 - Genomics and proteomics may have lost some of their luster on Wall Street in recent months, but on Aliceanna Street here at the American Society for Microbiology Biodefense conference these subdisciplines have found a home. Along with several presentations, a good 20 percent of the posters presented applications of large-scale gene and protein analysis to understanding of pathogens and how to combat them.
Registering provides access to this and other free content.
Already have an account?Login Now.
The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.
Kaiser Health News reports that gene therapies could cost more than a million dollars.
Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.
In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.